반응식
[C:1]1([CH:9]=[CH:10][C:11]2[CH:17]=[CH:16][C:14]([OH:15])=[CH:13][CH:12]=2)[CH:8]=[C:6]([OH:7])[CH:5]=[C:3]([OH:4])[CH:2]=1.CS(C)=O.CCN(C1C=CC2N=C3C(OC=2C=1)=CC(=O)C1C3=CC=CC=1)CC.[C:46]([NH2:54])(=[O:53])[C:47]1[CH:52]=[CH:51][CH:50]=[N:49][CH:48]=1>C(O)C>[C:1]1([CH:9]=[CH:10][C:11]2[CH:17]=[CH:16][C:14]([OH:15])=[CH:13][CH:12]=2)[CH:8]=[C:6]([OH:7])[CH:5]=[C:3]([OH:4])[CH:2]=1.[C:46]([NH2:54])(=[O:53])[C:47]1[CH:52]=[CH:51][CH:50]=[N:49][CH:48]=1참가 물질
6
실험 절차
Resveratrol (Indofine #024964) was dissolved in Ethanol or DMSO to a 10 mM stock solution. Resveratrol was added to 60 mm NGM agar dishes containing either OP50 or RNAi expressing bacteria (HT115) to a final concentration of 10 μm, 50 μm, and 100 μM. Nile Red was also added to plates to a final concentration of 0.05 μg/ml. Nicotinamide (Supelco #47865-U) was diluted in PBS including Nile Red and added to 60 mM dishes containing OP50 to a final concentration of 1 mM, 10 mM, or 100 mM.
후처리
- additioncontaining either OP50 or RNAi
- additionadded to 60 mM dishes
- additioncontaining OP50 to a final concentration of 1 mM, 10 mM, or 100 mM
출처 및 근거
- ORD 기록
- ord-11c904f08c0e48c3975906bf19100cba
- 출처 데이터셋
- uspto-grants-2012_08
- 특허 번호
- US08242171B2
연결된 노트
불러오는 중…